Amedeo Smart

Free Medical Literature Service

 

Amedeo

Alzheimer's Disease
  Free Subscription

09.02.2026

19 Alzheimers Dement
1 Biochemistry
2 Curr Alzheimer Res
1 Curr Opin Neurol
2 Exp Gerontol
10 J Alzheimers Dis
1 J Biol Chem
1 J Neurol
1 Nat Med
1 Nature
1 Neurobiol Dis
3 Neurology
1 Neuroscience
2 Proc Natl Acad Sci U S A


    Alzheimers Dement

  1. PUECH C, Sadanand A, Coleman N, Ikhane M, et al
    APP-mediated intracellular signaling rescues sleep impairment and blood-brain barrier leakage in Alzheimer's disease mouse model.
    Alzheimers Dement. 2026;22:e71134.
    >> Share

  2. PEYTON M, Jury-Garfe N, Liu J, Beimfohr C, et al
    Single-cell analysis reveals neuroprotective histone deacetylase inhibitor pathways.
    Alzheimers Dement. 2026;22:e71108.
    >> Share

  3. CAI Y, Snitz BE, Cohen AD
    Associations between accelerometer-derived physical activity complexity, cognitive function, and plasma biomarkers of Alzheimer's disease.
    Alzheimers Dement. 2026;22:e71181.
    >> Share

  4. KIM S, Kremen S, Danovitch I, Lahiri S, et al
    Urinary tract infection-related delirium in Alzheimer's disease and related dementias: Clinical challenges and translational opportunities.
    Alzheimers Dement. 2026;22:e71184.
    >> Share

  5. FALGAS N, Tort-Colet N, Martin-Sobrino I, Maya G, et al
    Relationship between locus coeruleus and slow-wave sleep in aging and Alzheimer's disease.
    Alzheimers Dement. 2026;22:e71183.
    >> Share

  6. MORCILLO-NIETO AO, Rozalem-Aranha M, Maure-Blesa L, Rodriguez-Baz I, et al
    Temporal dynamics of white matter hyperintensities related to Alzheimer's disease in adults with Down syndrome.
    Alzheimers Dement. 2026;22:e71157.
    >> Share

  7. YE Q, Gao W, Feng J, Li X, et al
    Spatial heterogeneity in microglia-complement crosstalk: Implications for synaptic pruning in Alzheimer's disease.
    Alzheimers Dement. 2026;22:e71185.
    >> Share


  8. Correction to "The microbiota-gut-brain axis in mild cognitive impairment and Alzheimer's disease: A scoping review of human studies".
    Alzheimers Dement. 2026;22:e71221.
    >> Share

  9. FU X, Zhang J, Xiao Q, Li T, et al
    Deep cervical lymphatic-venous anastomosis attenuates cognitive dysfunction and biomarker abnormalities in severe Alzheimer's disease: A prospective single-arm study.
    Alzheimers Dement. 2026;22:e71150.
    >> Share

  10. LOCKHART SN, Sutphen CL, Tanley J, Gonzalez-Ortiz F, et al
    Plasma and neuroimaging biomarkers of small vessel disease and Alzheimer's disease in a diverse cohort: MESA.
    Alzheimers Dement. 2026;22:e71131.
    >> Share

  11. VAN DER VLIET D, de Vries LE, Di X, Wever D, et al
    Reduced triacylglycerols and lipid droplets are associated with resilience to Alzheimer's disease.
    Alzheimers Dement. 2026;22:e71083.
    >> Share

  12. DALLAIRE-THEROUX C, Denis HL, Cottez R, Tremblay C, et al
    Distinct alterations of adiponectin, fibroblast growth factor 21 (FGF-21), and insulin-like growth factor binding protein 2 (IGFBP-2) link dysmetabolism with cognitive decline across the Alzheimer's disease spectrum.
    Alzheimers Dement. 2026;22:e71097.
    >> Share

  13. KANTARCI K, Kara F, Tosakulwong N, Fought AJ, et al
    Long-term amyloid PET and MRI outcomes in a menopausal hormone therapy trial.
    Alzheimers Dement. 2026;22:e71067.
    >> Share

  14. WEAR D, Morrone CD, Simpson D, Liu F, et al
    Sex-specific acceleration of Alzheimer's pathogenesis by chronic sleep-deprivation.
    Alzheimers Dement. 2026;22:e71099.
    >> Share

  15. CHENG A, Zou Y, Liu L, Wang H, et al
    APOE4 and cognition in intracranial atherosclerosis: beyond Alzheimer's pathology.
    Alzheimers Dement. 2026;22:e71087.
    >> Share

  16. GIARDINA SF, Culver A, Ahmed C, Mirescu C, et al
    From consortia discovery to biotech creation: An innovative approach to next-gen Alzheimer's drugs.
    Alzheimers Dement. 2026;22:e71165.
    >> Share

  17. PUGH DA, Cary GA, Greathouse KM, Nassour-Caswell LC, et al
    NRN1 as a therapeutic target for Alzheimer's disease.
    Alzheimers Dement. 2026;22:e71149.
    >> Share

  18. KUSHWAHA S, Roy Choudhury R, Bhat P, Kumaran SS, et al
    Female-biased astrocytic priming shapes early locus coeruleus vulnerability in an Abeta oligomer milieu.
    Alzheimers Dement. 2026;22:e71168.
    >> Share

  19. HOU XH, Zhang W, Kang K, Jin Y, et al
    Proteomics reveals three molecular subtypes of Alzheimer's disease with distinct progression patterns.
    Alzheimers Dement. 2026;22:e71106.
    >> Share


    Biochemistry

  20. KASS B, Poschmann G, Demir F, Huesgen P, et al
    The Proteome of Human Amyloid Beta Oligomers.
    Biochemistry. 2026;65:339-353.
    >> Share


    Curr Alzheimer Res

  21. RAUDINO F
    History of Senile Dementia from the Antiquity to the Beginning of the Modern Age.
    Curr Alzheimer Res. 2025;22:502-509.
    >> Share

  22. MEHRABADI S, Barati S
    Exploring the Interconnections of Genetic, Lifestyle, and Epigenetic Influences on Brain Aging: A Comprehensive Review.
    Curr Alzheimer Res. 2025;22:488-501.
    >> Share


    Curr Opin Neurol

  23. EYSERT F, Deportes G, Delaquaize E, Chami M, et al
    Peripheral alterations of mitochondrial function and mitophagy in Alzheimer's disease: from fundamental research to clinical perspectives.
    Curr Opin Neurol. 2026 Jan 30. doi: 10.1097/WCO.0000000000001457.
    >> Share


    Exp Gerontol

  24. LIU D, Yang H, Feng X, Hou M, et al
    Probucol attenuates bone loss in APP/PS1 mice and ameliorates Abeta42-induced osteoblast dysfunction by regulating AKT/FOXO3a signaling pathway.
    Exp Gerontol. 2026;214:113034.
    >> Share

  25. YAO LL, Ma XT, Li FB, Zheng LY, et al
    Correlation between sarcopenia and changes in oligodendrocyte lineage cells in the brains of Alzheimer's disease model mice.
    Exp Gerontol. 2026 Feb 3:113057. doi: 10.1016/j.exger.2026.113057.
    >> Share


    J Alzheimers Dis

  26. AHMED A, Khan H, Shen Y, Xu S, et al
    Neuroprotective potential of Rhus coriaria: Insights into acetylcholinesterase inhibition and amyloid-beta modulation.
    J Alzheimers Dis. 2026;109:1053-1067.
    >> Share

  27. LEE LH, Chou CJ, Shih YC, Fang YM, et al
    Relationship between amyloid burden, cholinergic integrity, and cognitive function.
    J Alzheimers Dis. 2026;109:1319-1330.
    >> Share

  28. HARRIS M, Bateman JR, Shaaban CE, Becker J, et al
    Certainty-weighted recognition memory: Potential applications for early detection and metacognition.
    J Alzheimers Dis. 2026;109:1380-1390.
    >> Share

  29. MICHOPOULOU S, Prosser A, O'Brien N, Dickson J, et al
    Alzheimer's disease diagnosis support for brain perfusion SPECT scans in a real-world clinical cohort.
    J Alzheimers Dis. 2026 Jan 30:13872877251413790. doi: 10.1177/13872877251413790.
    >> Share

  30. GARCIA-CARLOS CA, Salas-Gallardo A, Gonzalez-Pereyra P, Basurto-Islas G, et al
    Amyloid-beta and phosphorylated-tau accumulation in retrosplenial cortex of young Alzheimer's disease model: Impact on network activity.
    J Alzheimers Dis. 2026 Feb 2:13872877261417377. doi: 10.1177/13872877261417377.
    >> Share

  31. CHEN H, Zhang H, Yang M, Xie Q, et al
    Association between apolipoprotein E gene polymorphisms and serum lipid indicators and Alzheimer's disease risk.
    J Alzheimers Dis. 2026 Feb 2:13872877261416064. doi: 10.1177/13872877261416064.
    >> Share

  32. GUO F, Sheng ZH, Li T, Huang LY, et al
    Associations of plasma sphingomyelin SM (d18:1/24:0) with Alzheimer's disease pathology and cognition in non-demented adults.
    J Alzheimers Dis. 2026 Feb 2:13872877251415349. doi: 10.1177/13872877251415349.
    >> Share

  33. EMEKEEVA DD, Chen J, Yang Y, Yang J, et al
    Mapping protein variants associated with Alzheimer's disease by mass-spectrometry based de novo sequencing assisted strategy.
    J Alzheimers Dis. 2026 Feb 3:13872877251414414. doi: 10.1177/13872877251414414.
    >> Share

  34. TRIPANPITAK K, Wolf A, Kapitonova M, Umeda S, et al
    Biomarkers for Alzheimer's disease and mild cognitive impairment: Recent advances in task-based EEG.
    J Alzheimers Dis. 2026 Feb 4:13872877251413700. doi: 10.1177/13872877251413700.
    >> Share

  35. BRENOWITZ WD, Ehrlich JR, Deal JA, Yaffe K, et al
    Introduction to Supplemental Issue: Sensory loss in Alzheimer's disease and related dementias.
    J Alzheimers Dis. 2026 Feb 5:13872877261418685. doi: 10.1177/13872877261418685.
    >> Share


    J Biol Chem

  36. TSAKA G, Pages AM, De Sousa CB, Lammertyn J, et al
    Conformation-specific monoclonal antibodies reveal early Tau structural intermediates in Alzheimer's disease.
    J Biol Chem. 2026 Feb 3:111221. doi: 10.1016/j.jbc.2026.111221.
    >> Share


    J Neurol

  37. CECCHINI MA, Studart-Neto A, Moraes NC, Carneiro CG, et al
    Short-term memory conjunctive binding in subjective cognitive decline: A PET biomarker-based study.
    J Neurol. 2026;273:107.
    >> Share


    Nat Med

  38. HEALEY N
    Blood tests for Alzheimer's disease could reshape research and care.
    Nat Med. 2026 Feb 5. doi: 10.1038/d41591-026-00008.
    >> Share


    Nature

  39. ZETTERBERG H, Bendlin BB
    Biofluid biomarkers in Alzheimer's disease and other neurodegenerative dementias.
    Nature. 2026;650:49-59.
    >> Share


    Neurobiol Dis

  40. LANZILLOTTA S, Boccardi V, Zulli B, Napoli A, et al
    GDF-11, GDF-15, Jag-1, and leptin in neuronal-derived extracellular vesicles as aging-related biomarkers to identify individuals at risk of Alzheimer's dementia: A pilot study.
    Neurobiol Dis. 2026;220:107291.
    >> Share


    Neurology

  41. VRILLON A, Spina S, Mejia-Perez J, Lamore T, et al
    Association of [(18)F]Flortaucipir-PET and Plasma p-Tau217 With Tau Neuropathology in Alzheimer Disease and Other Neurodegenerative Disorders.
    Neurology. 2026;106:e214576.
    >> Share

  42. NELSON PT, Jicha GA
    Tau Biomarker-Based Diagnosis of Alzheimer Disease and the Anti-Abeta Therapeutic Window: Is There Overlap?
    Neurology. 2026;106:e214696.
    >> Share

  43. HALL BJ, Aumont E, Hosseini SA, Fernandez Arias J, et al
    Association of Cortical Free Water With Brain Tau Tangle Load in the Alzheimer Disease Continuum.
    Neurology. 2026;106:e214606.
    >> Share


    Neuroscience

  44. DENVER P, Duffy A, Kennedy RT, Gault VA, et al
    Therapeutic efficacy of synthetic analogues of gut hormones in a mouse model of Alzheimer's disease.
    Neuroscience. 2026 Jan 28:S0306-4522(26)00075.
    >> Share


    Proc Natl Acad Sci U S A

  45. OLCHANYI MD, Schreier DR, Li J, Maffei C, et al
    Probabilistic mapping and automated segmentation of human brainstem white matter bundles.
    Proc Natl Acad Sci U S A. 2026;123:e2509321123.
    >> Share

  46. CEN Y, R Alves S, Song D, Felice C, et al
    PTP1B inhibition promotes microglial phagocytosis in Alzheimer's disease models by enhancing SYK signaling.
    Proc Natl Acad Sci U S A. 2026;123:e2521944123.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016